NO995935L - 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose - Google Patents
17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meioseInfo
- Publication number
- NO995935L NO995935L NO995935A NO995935A NO995935L NO 995935 L NO995935 L NO 995935L NO 995935 A NO995935 A NO 995935A NO 995935 A NO995935 A NO 995935A NO 995935 L NO995935 L NO 995935L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- thio
- independently hydrogen
- meiosis
- alloxy
- Prior art date
Links
- 230000021121 meiosis Effects 0.000 title abstract 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000035558 fertility Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97201691 | 1997-06-04 | ||
| PCT/EP1998/003191 WO1998055498A1 (en) | 1997-06-04 | 1998-05-28 | 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995935D0 NO995935D0 (no) | 1999-12-03 |
| NO995935L true NO995935L (no) | 2000-02-03 |
Family
ID=8228406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995935A NO995935L (no) | 1997-06-04 | 1999-12-03 | 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6262282B1 (zh) |
| EP (1) | EP0988312B1 (zh) |
| JP (1) | JP2002502404A (zh) |
| KR (1) | KR20010013401A (zh) |
| CN (1) | CN1259138A (zh) |
| AT (1) | ATE215555T1 (zh) |
| AU (1) | AU8535398A (zh) |
| CA (1) | CA2289524A1 (zh) |
| DE (1) | DE69804611T2 (zh) |
| DK (1) | DK0988312T3 (zh) |
| HU (1) | HUP0002904A2 (zh) |
| IL (1) | IL132799A0 (zh) |
| NO (1) | NO995935L (zh) |
| PL (1) | PL337188A1 (zh) |
| TR (1) | TR199902873T2 (zh) |
| WO (1) | WO1998055498A1 (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1042353T3 (da) * | 1997-12-18 | 2002-11-04 | Akzo Nobel Nv | 17-beta-aryl(arylmethyl)oxy(thio)alkylandrostanderivater |
| BR9910415A (pt) * | 1998-05-13 | 2001-01-09 | Novo Nordisk As | Novos compostos, uso de compostos, e, processo de regular a meiose |
| KR20010053031A (ko) * | 1998-06-19 | 2001-06-25 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | 감수분열 조절 화합물 |
| DE60034662T2 (de) | 1999-02-24 | 2008-01-03 | Novo Nordisk A/S | Behandlung von unfruchtbarkeit |
| BR0008468A (pt) * | 1999-02-24 | 2002-02-05 | Novo Nordisk As | Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos |
| WO2000051618A1 (en) * | 1999-03-02 | 2000-09-08 | Akzo Nobel N.V. | (ANDROST-5-EN-17β-YL)ALKYL SULFOXIDES AND SULFONES AND THEIR USE FOR CONTROL OF FERTILITY |
| US6756366B1 (en) * | 1999-04-06 | 2004-06-29 | Akzo Nobel N.V. | Orally active androgens |
| CN1222319C (zh) | 1999-09-16 | 2005-10-12 | 诺沃挪第克公司 | 用于体外受精的组合物 |
| EP1127890A1 (en) | 2000-02-22 | 2001-08-29 | Schering Aktiengesellschaft | Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments |
| AU3376501A (en) * | 2000-02-25 | 2001-09-03 | Novo Nordisk A/S | Improvement of implantation rate |
| US20040224878A1 (en) * | 2000-05-18 | 2004-11-11 | Suna Cukurcam | Fertilization of aged oocytes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5716777A (en) * | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
| CA2214126A1 (en) | 1995-03-06 | 1996-09-12 | Novo Nordisk A/S | Stimulation of meiosis |
| DE69630802T2 (de) | 1995-06-23 | 2004-08-12 | Novo Nordisk A/S | Meiose regulierende verbindungen. |
-
1998
- 1998-05-28 TR TR1999/02873T patent/TR199902873T2/xx unknown
- 1998-05-28 IL IL13279998A patent/IL132799A0/xx unknown
- 1998-05-28 DK DK98936293T patent/DK0988312T3/da active
- 1998-05-28 AT AT98936293T patent/ATE215555T1/de not_active IP Right Cessation
- 1998-05-28 KR KR19997011402A patent/KR20010013401A/ko not_active Application Discontinuation
- 1998-05-28 AU AU85353/98A patent/AU8535398A/en not_active Abandoned
- 1998-05-28 PL PL98337188A patent/PL337188A1/xx unknown
- 1998-05-28 WO PCT/EP1998/003191 patent/WO1998055498A1/en not_active Application Discontinuation
- 1998-05-28 CA CA002289524A patent/CA2289524A1/en not_active Abandoned
- 1998-05-28 JP JP50144599A patent/JP2002502404A/ja not_active Ceased
- 1998-05-28 CN CN98805807A patent/CN1259138A/zh active Pending
- 1998-05-28 EP EP98936293A patent/EP0988312B1/en not_active Expired - Lifetime
- 1998-05-28 US US09/445,202 patent/US6262282B1/en not_active Expired - Fee Related
- 1998-05-28 HU HU0002904A patent/HUP0002904A2/hu unknown
- 1998-05-28 DE DE69804611T patent/DE69804611T2/de not_active Expired - Fee Related
-
1999
- 1999-12-03 NO NO995935A patent/NO995935L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998055498A1 (en) | 1998-12-10 |
| TR199902873T2 (xx) | 2000-04-21 |
| KR20010013401A (ko) | 2001-02-26 |
| CA2289524A1 (en) | 1998-12-10 |
| ATE215555T1 (de) | 2002-04-15 |
| DE69804611D1 (de) | 2002-05-08 |
| JP2002502404A (ja) | 2002-01-22 |
| HUP0002904A2 (hu) | 2001-02-28 |
| DE69804611T2 (de) | 2002-10-02 |
| IL132799A0 (en) | 2001-03-19 |
| DK0988312T3 (da) | 2002-07-15 |
| AU8535398A (en) | 1998-12-21 |
| US6262282B1 (en) | 2001-07-17 |
| EP0988312B1 (en) | 2002-04-03 |
| CN1259138A (zh) | 2000-07-05 |
| EP0988312A1 (en) | 2000-03-29 |
| NO995935D0 (no) | 1999-12-03 |
| PL337188A1 (en) | 2000-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO995935L (no) | 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose | |
| ES2124545T3 (es) | Azolidindionas como agentes antihiperglucemicos. | |
| MY111702A (en) | 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative | |
| NO995590D0 (no) | 20-Aryl-5<alfa>-pregnan-derivater | |
| DE69623497D1 (de) | 1-methylcarbapenem-derivate | |
| ATE79629T1 (de) | 17-substituierte androsta-1,4-dien-3-on-derivate. | |
| ES472085A1 (es) | Un procedimiento para la preparacion de una composicion te- rapeutica para el tratamiento de enfermedades alergicas. | |
| ES2080182T3 (es) | Derivados espiro dibenzosuberano. | |
| NO921282L (no) | Benzotiazolderivater og deres anvendelse | |
| ATE86117T1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| ATE220686T1 (de) | 17beta-aryl(arylmethyl)oxy(thio)alkyl- androstanderivative | |
| EP1112998A4 (en) | AMINE DERIVATIVES | |
| ATE255111T1 (de) | Abeo-ergolinderivate als 5ht1a liganden | |
| NO924947L (no) | Tetrazolderivater og legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |